1. Out-of-pocket costs increased by 94;SE = standard error Antineoplastic expenditures rose dramatically threefold, from $9.78 billion in 2010 to $35.12 billion in 2021
2. Using Appropriate Price Indices for Analyses of Health Care Expenditures or Income Across Multiple Years. The Agency for Healthcare Research and Quality, 2022. Medical Expenditure Panel Survey;Types of cancer treatment,2017